PBV Stock Overview
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Prestige Consumer Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$64.00 |
| 52 Week High | US$68.50 |
| 52 Week Low | US$51.50 |
| Beta | 0.53 |
| 1 Month Change | 1.59% |
| 3 Month Change | 1.59% |
| 1 Year Change | 19.63% |
| 3 Year Change | 64.95% |
| 5 Year Change | 134.91% |
| Change since IPO | 366.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| PBV | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -3.8% | 3.8% | 1.9% |
| 1Y | 19.6% | -25.3% | 4.6% |
Return vs Industry: PBV exceeded the German Pharmaceuticals industry which returned -25.3% over the past year.
Return vs Market: PBV exceeded the German Market which returned 4.6% over the past year.
Price Volatility
| PBV volatility | |
|---|---|
| PBV Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PBV has not had significant price volatility in the past 3 months.
Volatility Over Time: PBV's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 560 | Ron Lombardi | www.prestigebrands.com |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.
Prestige Consumer Healthcare Inc. Fundamentals Summary
| PBV fundamental statistics | |
|---|---|
| Market cap | €3.22b |
| Earnings (TTM) | -€74.81m |
| Revenue (TTM) | €1.05b |
3.1x
P/S Ratio-43.3x
P/E RatioIs PBV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PBV income statement (TTM) | |
|---|---|
| Revenue | US$1.13b |
| Cost of Revenue | US$500.02m |
| Gross Profit | US$634.21m |
| Other Expenses | US$714.88m |
| Earnings | -US$80.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -1.62 |
| Gross Margin | 55.92% |
| Net Profit Margin | -7.11% |
| Debt/Equity Ratio | 74.9% |
How did PBV perform over the long term?
See historical performance and comparison